While the infant formula segment is driving toward premiumization, fierce competition continues, especially in China, which has accounted for almost half of the global market size. Can probiotics help boost market growth? Explore the opportunities of the well-studied human-residential Bifidobacterium (HRB) strain - Bifidobacterium longum BB536 for use in infant formula.

This Technical Paper is from Morinaga Milk.